Afuco™ Anti-Human H2BFM ADCC Therapeutic Antibody, ADCC Enhanced
Anti-H2BFM ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies bind to a human histone protein, such as H2B, H3 or H4 are of use to treat a variety of diseases that may be associated with histones, such as autoimmune disease, atherosclerosis, arthritis, rheumatoid arthritis, edema, sepsis, septic shock, hyperinflammatory disorder, infectious disease, inflammatory disease, immune dysregulatory disorder, GVHD, transplant rejection, atherosclerosis, asthma, a coagulopathy, myocardial ischemia, thrombosis, nephritis, inflammatory liver injury, acute pancreatitis, ischemia-reperfusion injury, stroke, cardiovascular disease, and burn.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-321CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | H2BFM |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤1 year at -20°C. |